Results 31 to 40 of about 9,814,118 (327)
Cautionary notes on the use of NF-κB p65 and p50 antibodies for CNS studies
Journal of Neuroinflammation, 2011 Background The characterization and cellular localization of transcription factors like NF-κB requires the use of antibodies for western blots and immunohistochemistry.
Listwak Samuel J +3 more
doaj +1 more source
IgM Antibodies Can Access Cryptic Antigens Denied to IgG: Hypothesis on Novel Binding Mechanism
Frontiers in Immunology, 2019 Antibodies are well-known protein mediators of immunity. IgM is the primordial member and the neglected sibling of the later-evolved and more proficient IgG in regard to their therapeutic and diagnostic use.
Eric Chun Yiu Law +7 more
doaj +1 more source
Frontiers in Immunology, 2020 In human lupus nephritis, tubulointerstitial inflammation (TII) is associated with in situ expansion of B cells expressing anti-vimentin antibodies (AVAs). The mechanism by which AVAs are selected is unclear.
Andrew J. Kinloch +8 more
doaj +1 more source
FEBS Letters, 1984 Bovine serum albumin conjugates of guanosine prepared by the periodate method was used as immunogen to elicit guanosine antibodies in rabbits. The specificities of the antibodies were studied by the inhibition of their binding to [3H]Gox‐red, [32P]DNA and [3H]RNA by related non‐radioactive compounds.
Iswari, S, Jacob, TM
openaire +3 more sources
eLife, 2020 Antibodies are critical components of adaptive immunity, binding with high affinity to pathogenic epitopes. Antibodies undergo rigorous selection to achieve this high affinity, yet some maintain an additional basal level of low affinity, broad reactivity
Christopher T Boughter +6 more
doaj +1 more source
Structurally Mapping Antibody Repertoires
Frontiers in Immunology, 2018 Every human possesses millions of distinct antibodies. It is now possible to analyze this diversity via next-generation sequencing of immunoglobulin genes (Ig-seq).
Konrad Krawczyk +16 more
doaj +1 more source
Emerging Infectious Diseases, 2020 A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerged to cause a human pandemic. Although molecular diagnostic tests were rapidly developed, serologic assays are still lacking, yet urgently needed ...
Nisreen M. A. Okba +18 more
semanticscholar +1 more source
Antibody variable region engineering for improving cancer immunotherapy
Cancer Communications, 2022 The efficacy and specificity of conventional monoclonal antibody (mAb) drugs in the clinic require further improvement. Currently, the development and application of novel antibody formats for improving cancer immunotherapy have attracted much attention.
Hantao Lou, Xuetao Cao
doaj +1 more source
Platelet antibody of blood donors in Suzhou
Zhongguo shuxue zazhi, 2022 Objective To study the incidence and specificity of platelet antibody in blood donors in Suzhou, analyze the distribution characteristics of platelet antibody in blood donors in this area, and explore the significance of platelet antibody detection in ...
Li DONG +8 more
doaj +1 more source
Antibody Detection and Dynamic Characteristics in Patients with COVID-19
Clinical Infectious Diseases, 2020 Background The corona virus disease 2019 (COVID-19) caused by the corona virus 2 (SARS-CoV-2) has been rapidly spreading nationwide and abroad. A serologic test to identify antibody dynamics and response to SARS-CoV-2 was developed.
Fei-Xiang Xiang +12 more
semanticscholar +1 more source